Nano-X Imaging (NNOX) Net Income towards Common Stockholders (2019 - 2025)
Nano-X Imaging (NNOX) reported Net Income towards Common Stockholders of -$36.8 million for Q4 2025, down 157.99% on a YoY basis from $63.4 million in Q4 2024, and down 165.0% quarter-over-quarter from -$13.9 million in Q3 2025.
Nano-X Imaging (NNOX) Net Income towards Common Stockholders (2019 - 2025) Analysis & Trends
Nano-X Imaging has reported Net Income towards Common Stockholders for 7 years, with the latest figure at -$36.8 million in Q4 2025.
- For the quarter ending Q4 2025, Net Income towards Common Stockholders fell 157.99% year-over-year to -$36.8 million; the trailing twelve-month figure through Dec 2025 stood at -$78.6 million (down 44.94% YoY), and the FY2025 full-year result was -$43.1 million, down 10.84% from the prior year.
- Net Income towards Common Stockholders for Q4 2025 stood at -$36.8 million, down from -$13.9 million in the prior quarter.
- The five-year high for Net Income towards Common Stockholders was -$10.4 million in Q4 2023, with the low at -$54.9 million in Q4 2022.
- Historically, Net Income towards Common Stockholders has averaged -$18.8 million across 5 years, with a median of -$14.1 million in 2024.
- Annual changes were most pronounced in 2021 — Net Income towards Common Stockholders plunged 163.34% — and 2023, when it surged 81.05%.
- Nano-X Imaging's Net Income towards Common Stockholders stood at -$22.1 million in 2021, then tumbled by 148.07% to -$54.9 million in 2022, then surged by 81.05% to -$10.4 million in 2023, then slumped by 36.93% to -$14.2 million in 2024, then tumbled by 157.99% to -$36.8 million in 2025.
- The last three Net Income towards Common Stockholders figures came in at -$36.8 million (Q4 2025), -$13.9 million (Q3 2025), and -$14.6 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 411.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 187,319.30 |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 199.50 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | Nano-X Imaging | 3.77 Mn | -55.84 Mn | -3.62 Mn | -36.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -36.76 Mn |
| Sep 30, 2025 | -13.87 Mn |
| Jun 30, 2025 | -14.56 Mn |
| Mar 31, 2025 | -13.41 Mn |
| Dec 31, 2024 | -14.25 Mn |
| Sep 30, 2024 | -13.83 Mn |
| Jun 30, 2024 | -13.73 Mn |
| Mar 31, 2024 | -12.43 Mn |
| Dec 31, 2023 | -10.41 Mn |
| Sep 30, 2023 | -21.56 Mn |
| Jun 30, 2023 | -17.54 Mn |
| Mar 31, 2023 | -11.95 Mn |
| Dec 31, 2022 | -54.90 Mn |
| Sep 30, 2022 | -19.92 Mn |
| Jun 30, 2022 | -23.81 Mn |
| Mar 31, 2022 | -21.97 Mn |
| Dec 31, 2021 | -22.13 Mn |
| Sep 30, 2021 | -13.47 Mn |
| Jun 30, 2021 | -13.58 Mn |
| Mar 31, 2021 | -12.72 Mn |